CD44 and cancer: Many studies have reported that CRC cancer cells in spheroids express markers associated with stemness phenotypes such as CD133, CD44, CD44v6, CD166, and Lgr5 [17,18,19,20], the latter widely used to study CRC cancer stem-like cells both in in vitro and in vivo models [21,22].